×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Anda
Anda
Trump Tariff – How much can it hurt Indian pharma?
Lupin receives US FDA approval for generic anti-fungal drug
Alembic receives US tentative approval for Dasatinib tablets
Cipla gets final nod from USFDA for migraine treatment nasal spray
JB Chemicals Gujarat unit passes USFDA inspection with one observation
Strides to acquire 18 abbreviated new drug applications from Pharmaceutics International, Inc
Granules Pharmaceuticals, Inc gets USFDA nod for Colchicine tablets
Will 2020 be the year of the pharma sector?
Unichem Labs gets USFDA nod to market anxiety disorder tablets
Alembic Pharma gets USFDA nod for 2 generic products
Lupin gets 5 observations from USFDA for Pithampur Unit-3 facility
Glenmark gets USFDA nod for contraceptive drug
Zydus Cadila gets USFDA nod for blood pressure treatment drug
Zydus gets USFDA nod for seizure, migraine drug
Granules US partner gets ANDA approval for heart drug
Glenmark looks to file up to 25 product applications annually
USFDA hikes fee for processing ANDA by $1 lakh for FY18
Wockhardt's antibiotic injection gets USFDA nod
Alembic Pharma gets USFDA go-ahead for anti-bacterial drug
Cipla eyes filing over 20 ANDAs in US this fiscal
Zydus Cadila gets USFDA nod for its ulcerative colitis drug
Jubilant Life Sciences gets USFDA nod for anti-depressive drug
Alembic gets tentative USFDA nod for erectile dysfunction drug
Alembic Pharma gets USFDA nod for anti-influenza drug
Jubilant gets USFDA nod for generic hypertension drug
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio